Paper36968199
Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells.
Rosado-Galindo H and 1 other. Front Cell Dev Biol, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells. Papers, record 36968199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P20 GM103475 | NIGMS NIH HHS | United States | P20GM103475 | PubMed | NIH RePORTER |
| SC1 GM131967 | NIGMS NIH HHS | United States | SC1GM131967 | PubMed and NIH | NIH RePORTER |
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29096610 | Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform. | BMC Cancer | 2017 | https://conductscience.org/library/papers/29096610 | PubMed |
| 2 | 21587162 | A simple hanging drop cell culture protocol for generation of 3D spheroids. | J Vis Exp | 2011 | https://conductscience.org/library/papers/21587162 | PubMed |
| 3 | 34917620 | TGF-β Signaling and Resistance to Cancer Therapy. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34917620 | PubMed |
| 4 | 34021045 | IL-9 Abrogates the Metastatic Potential of Breast Cancer by Controlling Extracellular Matrix Remodeling and Cellular Contractility. | J Immunol | 2021 | https://conductscience.org/library/papers/34021045 | PubMed |
| 5 | 29631491 | The Evolution of Polystyrene as a Cell Culture Material. | Tissue Eng Part B Rev | 2018 | https://conductscience.org/library/papers/29631491 | PubMed |
| 6 | 28273453 | CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response. | Cell Rep | 2017 | https://conductscience.org/library/papers/28273453 | PubMed |
| 7 | 30845999 | Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. | BMC Cancer | 2019 | https://conductscience.org/library/papers/30845999 | PubMed |
| 8 | 18516279 | The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. | Mol Oncol | 2007 | https://conductscience.org/library/papers/18516279 | PubMed |
| 9 | 32446364 | Extracellular biophysical environment: Guilty of being a modulator of drug sensitivity in ovarian cancer cells. | Biochem Biophys Res Commun | 2020 | https://conductscience.org/library/papers/32446364 | PubMed |
| 10 | 30175027 | Evaluation of cancer stemness in breast cancer and glioblastoma spheroids in vitro. | 3 Biotech | 2018 | https://conductscience.org/library/papers/30175027 | PubMed |
| 11 | 25893917 | Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/25893917 | PubMed |
| 12 | 28459445 | EGFR and HER2 activate rigidity sensing only on rigid matrices. | Nat Mater | 2017 | https://conductscience.org/library/papers/28459445 | PubMed |
| 13 | 31045815 | Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/31045815 | PubMed |
| 14 | 10880430 | The ErbB signaling network: receptor heterodimerization in development and cancer. | EMBO J | 2000 | https://conductscience.org/library/papers/10880430 | PubMed |
| 15 | 24827135 | Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. | Ann Oncol | 2014 | https://conductscience.org/library/papers/24827135 | PubMed |
| 16 | 28561056 | EGFR probes matrix stiffness. | Nat Cell Biol | 2017 | https://conductscience.org/library/papers/28561056 | PubMed |
| 17 | 18483277 | Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. | Cancer Res | 2008 | https://conductscience.org/library/papers/18483277 | PubMed |
| 18 | 22394363 | EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia. | J Recept Signal Transduct Res | 2012 | https://conductscience.org/library/papers/22394363 | PubMed |
| 19 | 27766946 | In vitro models of cancer stem cells and clinical applications. | BMC Cancer | 2016 | https://conductscience.org/library/papers/27766946 | PubMed |
| 20 | 34518591 | Analysis of the signal cross talk via CCL26 in the tumor microenvironment in osteosarcoma. | Sci Rep | 2021 | https://conductscience.org/library/papers/34518591 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40842015 | Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40842015 | PubMed |
| 39744427 | DUSP3 restrains the progression and stemness property of osteosarcoma through regulating EGFR/STAT3/SOX2 axis. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/39744427 | PubMed |
| 38280941 | Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback loop. | Oncogene | 2024 | https://conductscience.org/library/papers/38280941 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36968199
GET https://conductscience.org/api/papers/v1/36968199/references?page=2